April 18, 2024
12 min listen
Save
Healio Minute Podcast, Lung Cancer Edition: Top Headlines - Week of April 15, 2024
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this edition, durvalumab improves survival in limited-stage small cell lung cancer, most adults do not test homes for radon exposure and more.
Read the full coverage here:
Durvalumab improves survival in limited-stage small cell lung cancer
Survey: Most adults do not test homes for radon exposure, unconcerned about risks
FDA fast tracks investigational bispecific therapy for aggressive lung cancer
Research shows complexity of shared decision-making about lung cancer screening
Keytruda-Lynparza combination misses survival targets in phase 3 lung cancer trial
References:
Núñez E, et al. Ann Fam Med. 2024;doi:10.1370/afm.3081.
Published by:
Sources/Disclosures
Collapse
Disclosures:
Please see each study for relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
